Retrovirology (Oct 2009)

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

  • Aboulker J,
  • Guérin C,
  • Flys C,
  • Jackson A,
  • Ben Hamouda N,
  • Poizot-Martin I,
  • Bonnet B,
  • Pialoux G,
  • Lelièvre J,
  • Hénin Y,
  • Cuzin,
  • Surenaud M,
  • Desaint C,
  • Durier C,
  • Salmon-Céron D,
  • Choppin J,
  • Launay O

DOI
https://doi.org/10.1186/1742-4690-6-S3-O25
Journal volume & issue
Vol. 6, no. Suppl 3
p. O25

Abstract

Read online

No abstracts available.